{
    "clinical_study": {
        "@rank": "105881", 
        "acronym": "ROQ_NUTRIMETAB", 
        "arm_group": [
            {
                "arm_group_label": "NUTRIOSE", 
                "arm_group_type": "Experimental", 
                "description": "Group of volunteers fed with NUTRIOSE"
            }, 
            {
                "arm_group_label": "GLUCIDEX", 
                "arm_group_type": "Active Comparator", 
                "description": "Group of volunteers fed with GLUCIDEX"
            }
        ], 
        "brief_summary": {
            "textblock": "NUTRIOSE is a food ingredient defined as a carbohydrate polymer of vegetable origin (wheat\n      starch or corn) with a degree of polymerization  \u2265 3 and chemically transformed. It is\n      soluble in aqueous solution, very poorly digested in the small intestine, it  mostly reaches\n      the colon where it stimulates fermentation. AFSSA, in its opinion of July 30, 2007,\n      considers that this ingredient is a \"soluble dietary fiber.\" Recent work in China in\n      overweight volunteers have shown an effect of NUTRIOSE on satiation and satiety, and\n      demonstrate an effect on reducing weight and fat mass. By its action on satiety and reduced\n      food intake, the NUTRIOSE be of interest in the management of overweight or obese. Among the\n      possible mechanisms of action, are the metabolites produced by colonic fermentation of\n      NUTRIOSE.\n\n      The goal of this biomedical research is to study the effect of a dose of 14g/day of\n      NUTRIOSE FB06 for 12 weeks on the evolution of weight, percentage of body fat and digestive\n      tolerance in Caucasians overweight subjects. To gather evidence to support mechanisms of\n      action, it is proposed to measure before consumption, then every 4 weeks, the effects of\n      NUTRIOSE FB06 on satiety and satiation and changes in colonic flora and its metabolites."
        }, 
        "brief_title": "Effect of Nutriose Supplementation on Satiety, Weight Loss and Adiposity in Overweight Subjects", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Overweight", 
        "condition_browse": {
            "mesh_term": [
                "Weight Loss", 
                "Overweight"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy people\n\n          -  aged between 20 and 50 years\n\n          -  BMI between 27 and 29 kg/m2\n\n          -  without metabolic syndrome\n\n          -  no pregnant nor nursing women\n\n          -  covered by Social Security\n\n          -  negative serology for hepatitis B/C and HIV\n\n          -  who signed the informed consent form\n\n        Exclusion Criteria:\n\n          -  persons abusing drugs (laxatives, anti-diarrheal, agents acting on satiety)\n\n          -  person who doesn't want to stop taking food supplements containing pre- or probiotics\n             during time of the study\n\n          -  person intolerant to gluten and / or allergic to wheat flour\n\n          -  person in diet during the last 3 months\n\n          -  person in vegetarian or vegan diet\n\n          -  person who donated blood during the 3 months preceding the study\n\n          -  Inclusion in another clinical study\n\n          -  subjects receiving over 4,500 Euros in the last 12 months (including the present\n             study)\n\n          -  subjects presenting risk of non-compliance in the opinion of the recruiting doctor."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "76", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01897662", 
            "org_study_id": "ROQ_NUTRIMETAB10", 
            "secondary_id": "2011-A00062-39"
        }, 
        "intervention": [
            {
                "arm_group_label": "NUTRIOSE", 
                "description": "14g/day NUTRIOSE FB06: 7g in 250 mL orange juice twice a day", 
                "intervention_name": "NUTRIOSE FB06", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "GLUCIDEX", 
                "description": "7g/day GLUCIDEX 21 : 3.5g in 250 mL orange juice twice a day", 
                "intervention_name": "GLUCIIDEX 21", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "overweight", 
            "satiety", 
            "functional food", 
            "food intake", 
            "digestive tolerance"
        ], 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bondy", 
                    "country": "France", 
                    "state": "Seine-Saint-Denis", 
                    "zip": "93143"
                }, 
                "name": "CRNH, service de diab\u00e9tologie-endocrinologie-nutrition h\u00f4pital Jean Verdier"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of the Consumption of Nutriose on Satiety, Weight Loss and Fat Mass Reducing in Overweight Subjects", 
        "overall_official": {
            "affiliation": "centre de recherche en nutrition humaine (CRNH)", 
            "last_name": "Paul VALENSI, PU/PH, Chef de service", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "body weight", 
            "safety_issue": "No", 
            "time_frame": "D-7; D28; D56; D84"
        }, 
        "reference": [
            {
                "PMID": "21164548", 
                "citation": "Li S, Guerin-Deremaux L, Pochat M, Wils D, Reifer C, Miller LE. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study. Appl Physiol Nutr Metab. 2010 Dec;35(6):773-82. doi: 10.1139/H10-074."
            }, 
            {
                "PMID": "19215668", 
                "citation": "Slavin JL, Savarino V, Paredes-Diaz A, Fotopoulos G. A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res. 2009 Jan-Feb;37(1):1-17. Review."
            }, 
            {
                "PMID": "21591985", 
                "citation": "Guerin-Deremaux L, Li S, Pochat M, Wils D, Mubasher M, Reifer C, Miller LE. Effects of NUTRIOSE\u00ae dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men. Int J Food Sci Nutr. 2011 Sep;62(6):628-35. doi: 10.3109/09637486.2011.569492. Epub 2011 May 19."
            }, 
            {
                "PMID": "15870317", 
                "citation": "Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005 May;71(5):2318-24."
            }, 
            {
                "PMID": "20424341", 
                "citation": "Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J. 2010;57(5):359-72. Epub 2010 Apr 14. Review."
            }, 
            {
                "PMID": "12548293", 
                "citation": "Ruskon\u00e9-Fourmestraux A, Attar A, Chassard D, Coffin B, Bornet F, Bouhnik Y. A digestive tolerance study of maltitol after occasional and regular consumption in healthy humans. Eur J Clin Nutr. 2003 Jan;57(1):26-30."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01897662"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "satiety", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "energy intake", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "description": "Body Mass Index", 
                "measure": "BMI", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "description": "measured by DEXA", 
                "measure": "body fat", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "waist size", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "glycemia", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "insulinemia", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "LDL cholesterol", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "HDL cholesterol", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "triglyceridemia", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "description": "homeostasis model assessment (appreciates peripheral insulinoresistance and deficit in insulin secretion)", 
                "measure": "HOMA", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "description": "measured by RT-PCR", 
                "measure": "microbiota", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "measure": "blood pressure", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }, 
            {
                "description": "measured with daily questionnaires", 
                "measure": "digestive tolerance", 
                "safety_issue": "No", 
                "time_frame": "D-7; D28; D56; D84"
            }
        ], 
        "source": "Nealth Sarl", 
        "sponsors": {
            "collaborator": {
                "agency": "Roquette Freres", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Nealth Sarl", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}